Ye F - Search Results

1

Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice.

Ye F, Liu Y, Yu P, Li N, Wang Y, Xie X, Tang J. Ye F, et al. Cancer Med. 2020 Dec;9(23):8970-8978. doi: 10.1002/cam4.3595. Epub 2020 Nov 4. Cancer Med. 2020. PMID: 33145946 Free PMC article.

2

miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.

Tang H, Deng M, Tang Y, Xie X, Guo J, Kong Y, Ye F, Su Q, Xie X. Tang H, et al. Among authors: ye f. Clin Cancer Res. 2013 Oct 15;19(20):5602-12. doi: 10.1158/1078-0432.CCR-13-1326. Epub 2013 Aug 30. Clin Cancer Res. 2013. PMID: 23995857

3

miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.

Ye F, Tang H, Liu Q, Xie X, Wu M, Liu X, Chen B, Xie X. Ye F, et al. J Transl Med. 2014 Jan 21;12:17. doi: 10.1186/1479-5876-12-17. J Transl Med. 2014. PMID: 24447584 Free PMC article.

4

BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer.

Jiao S, Wu M, Ye F, Tang H, Xie X, Xie X. Jiao S, et al. Among authors: ye f. PLoS One. 2014 Mar 17;9(3):e92172. doi: 10.1371/journal.pone.0092172. eCollection 2014. PLoS One. 2014. PMID: 24637719 Free PMC article.

5

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.

Chen B, Tang H, Liu X, Liu P, Yang L, Xie X, Ye F, Song C, Xie X, Wei W. Chen B, et al. Among authors: ye f. Cancer Lett. 2015 Jan 28;356(2 Pt B):410-7. doi: 10.1016/j.canlet.2014.09.028. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304371

6

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Tang H, Liu P, Yang L, Xie X, Ye F, Wu M, Liu X, Chen B, Zhang L, Xie X. Tang H, et al. Among authors: ye f. Mol Cancer Ther. 2014 Dec;13(12):3185-97. doi: 10.1158/1535-7163.MCT-14-0243. Epub 2014 Oct 15. Mol Cancer Ther. 2014. PMID: 25319390

7

Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a.

Xiao X, Chen B, Liu X, Liu P, Zheng G, Ye F, Tang H, Xie X. Xiao X, et al. Among authors: ye f. PLoS One. 2014 Nov 14;9(11):e112720. doi: 10.1371/journal.pone.0112720. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2023 Dec 12;18(12):e0295991. doi: 10.1371/journal.pone.0295991 PMID: 25396727 Free PMC article. Retracted.

8

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

Liu P, Tang H, Chen B, He Z, Deng M, Wu M, Liu X, Yang L, Ye F, Xie X. Liu P, et al. Among authors: ye f. Cancer Lett. 2015 Feb 1;357(1):384-392. doi: 10.1016/j.canlet.2014.11.050. Epub 2014 Nov 27. Cancer Lett. 2015. PMID: 25434799

9

LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.

Yang L, Tang H, Kong Y, Xie X, Chen J, Song C, Liu X, Ye F, Li N, Wang N, Xie X. Yang L, et al. Among authors: ye f. Stem Cells. 2015 Oct;33(10):2913-24. doi: 10.1002/stem.2083. Epub 2015 Jul 14. Stem Cells. 2015. PMID: 26086949

10

miR-200c inhibits breast cancer proliferation by targeting KRAS.

Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye F, Xie X, Chen J, Tang H, Xie X. Song C, et al. Among authors: ye f. Oncotarget. 2015 Oct 27;6(33):34968-78. doi: 10.18632/oncotarget.5198. Oncotarget. 2015. PMID: 26392416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,578 results

Search Page

Filters